Insider Transactions in Q1 2022 at Adapt Health Corp. (AHCO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Sky Knight Capital Fund Ii, L.P. Director |
BUY
Open market or private purchase
|
Direct |
25,000
+1.0%
|
$375,000
$15.25 P/Share
|
|
Mar 11
2022
|
Sky Knight Capital Fund Ii, L.P. Director |
BUY
Open market or private purchase
|
Direct |
17,486
+0.71%
|
$262,290
$15.5 P/Share
|
|
Mar 04
2022
|
Sky Knight Capital Fund Ii, L.P. Director |
BUY
Open market or private purchase
|
Direct |
13,352
+0.54%
|
$200,280
$15.0 P/Share
|
|
Mar 03
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
32,342
+0.9%
|
$485,130
$15.44 P/Share
|
|
Mar 02
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,590
+0.94%
|
$23,850
$15.69 P/Share
|
|
Feb 28
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
465
-0.5%
|
$7,905
$17.43 P/Share
|
|
Feb 28
2022
|
Frank Mullen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.72%
|
$2,601
$17.43 P/Share
|
|
Feb 16
2022
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
4,973
+2.18%
|
-
|
|
Feb 16
2022
|
Daniel Bunting |
BUY
Grant, award, or other acquisition
|
Direct |
4,973
+6.21%
|
-
|
|
Feb 16
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,503
+3.77%
|
-
|
|
Feb 16
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,650
+6.7%
|
-
|
|
Feb 16
2022
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,120
+5.52%
|
-
|
|
Feb 16
2022
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,650
+1.09%
|
-
|
|
Feb 16
2022
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,738
+5.77%
|
-
|
|
Feb 01
2022
|
Daniel Bunting |
BUY
Grant, award, or other acquisition
|
Direct |
10,422
+12.94%
|
-
|
|
Feb 01
2022
|
Jason A Clemens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,670
+19.1%
|
-
|
|
Feb 01
2022
|
Stephen P Griggs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,617
+45.22%
|
-
|
|
Feb 01
2022
|
Christopher J Joyce General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,880
+22.64%
|
-
|
|
Feb 01
2022
|
Josh Parnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,617
+10.52%
|
-
|
|
Feb 01
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,348
-3.67%
|
-
|
|
Feb 01
2022
|
Albert A. Prast Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,113
+21.6%
|
-
|
|
Feb 01
2022
|
Shaw Rietkerk |
BUY
Grant, award, or other acquisition
|
Direct |
10,422
+4.56%
|
-
|
|
Jan 01
2022
|
Frank Mullen Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.53%
|
-
|
|
Jan 01
2022
|
Albert A. Prast Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-1.58%
|
-
|
|
Jan 01
2022
|
Christopher J Joyce General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,744
-3.78%
|
-
|